Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Camrelizumab Plus Apatinib in Extensive-Stage SCLC (PASSION): A Multicenter, Two-Stage, Phase 2 Trial
2020
138 citations
Journal Article
bronze Open Access
Field-Weighted Citation Impact:
6.11
·
Sir Run Run Shaw Hospital
Jianchun Duan
·
Chinese Academy of Medical Sciences & Peking Union Medical College
Caicun Zhou
·
Tongji University
Yanping Hu
·
Chinese PLA General Hospital
Haihua Yang
·
Nantong University
Yi Hu
·
Chinese PLA General Hospital
Jianying Zhou
·
Hangzhou First People's Hospital
Xiaoyan Lin
·
Fujian Medical University
Lifeng Wang
·
Nanjing Drum Tower Hospital
Zhijie Wang
·
Chinese Academy of Medical Sciences & Peking Union Medical College
Yanjun Xu
·
Zhejiang Cancer Hospital
Tao Zhang
·
Jiangsu Hengrui Medicine (China)
Wei Shi
·
Jiangsu Hengrui Medicine (China)
Jianjun Zou
·
Jiangsu Hengrui Medicine (China)
Jie Wang
·
Chinese Academy of Medical Sciences & Peking Union Medical College
Camrelizumab Plus Apatinib in Extensive-Stage SCLC (PASSION): A Multicenter, Two-Stage, Phase 2 Trial | Researchclopedia